Login
Research AI
Scans
Tools
Login
Home
Charts
Search
Watchlist
Products

Godrej Agrovet Ltd

GODREJAGRO·NSE
₹676.05+0.90%Thu, 24 Sept '26

Godrej Agrovet Ltd

GODREJAGRO
NSE
₹676.05
+0.90%
|Thu, 24 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹13,008Cr
Close
Close Price
₹676.05
Industry
Industry
FMCG Animal and Poultry
PE
Price To Earnings
29.11
PS
Price To Sales
1.24
Revenue
Revenue
₹10,474Cr
Rev Gr TTM
Revenue Growth TTM
8.58%
PAT Gr TTM
PAT Growth TTM
0.97%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
2,5712,3452,1342,3512,4492,4502,1342,6142,5672,7182,3332,855
Growth YoY
Revenue Growth YoY%
5.10.91.9-6.3-4.84.50.011.24.811.09.39.2
Expenses
ExpensesCr
2,3692,1861,9862,1252,2252,2301,9872,3452,3542,4772,1942,615
Operating Profit
Operating ProfitCr
201159148226223220147270213242139240
OPM
OPM%
7.86.86.99.69.19.06.910.38.38.96.08.4
Other Income
Other IncomeCr
202120252522252418-57827
Interest Expense
Interest ExpenseCr
282525304034293540352930
Depreciation
DepreciationCr
535356555857565857565857
PBT
PBTCr
1411028716615015187200135146130181
Tax
TaxCr
371922345441205251372853
PAT
PATCr
1048365132961106614984110102128
Growth YoY
PAT Growth YoY%
49.3-27.6179.022.9-7.832.40.913.1-11.9-0.154.7-13.8
NPM
NPM%
4.03.53.15.63.94.53.15.73.34.04.44.5
EPS
EPS₹
5.54.83.07.05.85.83.78.34.86.05.57.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
2,5712,3452,1342,3512,4492,4502,1342,6142,5672,7182,3332,855
Growth YoY
Revenue Growth YoY%
5.10.91.9-6.3-4.84.50.011.24.811.09.39.2
Expenses
ExpensesCr
2,3692,1861,9862,1252,2252,2301,9872,3452,3542,4772,1942,615
Operating Profit
Operating ProfitCr
201159148226223220147270213242139240
OPM
OPM%
7.86.86.99.69.19.06.910.38.38.96.08.4
Other Income
Other IncomeCr
202120252522252418-57827
Interest Expense
Interest ExpenseCr
282525304034293540352930
Depreciation
DepreciationCr
535356555857565857565857
PBT
PBTCr
1411028716615015187200135146130181
Tax
TaxCr
371922345441205251372853
PAT
PATCr
1048365132961106614984110102128
Growth YoY
PAT Growth YoY%
49.3-27.6179.022.9-7.832.40.913.1-11.9-0.154.7-13.8
NPM
NPM%
4.03.53.15.63.94.53.15.73.34.04.44.5
EPS
EPS₹
5.54.83.07.05.85.83.78.34.86.05.57.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,7504,9115,1865,9186,9646,2678,3069,3749,5619,38310,23310,474
Growth
Revenue Growth%
13.231.05.614.117.7-10.032.512.82.0-1.99.18.6
Expenses
ExpensesCr
3,4514,4734,7425,4626,4765,7037,6418,8518,8598,5679,3699,640
Operating Profit
Operating ProfitCr
300438443456488564665523701816864834
OPM
OPM%
8.08.98.57.77.09.08.05.67.38.78.48.0
Other Income
Other IncomeCr
185986015450901131399397116119
Interest Expense
Interest ExpenseCr
9886453442466399108133138133
Depreciation
DepreciationCr
52758698148154173185214226229228
PBT
PBTCr
335375372477349453542378473554612593
Tax
TaxCr
731021211284810612282113150167168
PAT
PATCr
261273251349301348419295359403445425
Growth
PAT Growth%
24.44.5-8.039.1-14.015.620.6-29.521.712.210.41.0
NPM
NPM%
7.05.64.85.94.35.55.03.13.84.34.34.0
EPS
EPS₹
14.912.612.017.015.916.321.015.718.722.424.623.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,7504,9115,1865,9186,9646,2678,3069,3749,5619,38310,23310,474
Growth
Revenue Growth%
13.231.05.614.117.7-10.032.512.82.0-1.99.18.6
Expenses
ExpensesCr
3,4514,4734,7425,4626,4765,7037,6418,8518,8598,5679,3699,640
Operating Profit
Operating ProfitCr
300438443456488564665523701816864834
OPM
OPM%
8.08.98.57.77.09.08.05.67.38.78.48.0
Other Income
Other IncomeCr
185986015450901131399397116119
Interest Expense
Interest ExpenseCr
9886453442466399108133138133
Depreciation
DepreciationCr
52758698148154173185214226229228
PBT
PBTCr
335375372477349453542378473554612593
Tax
TaxCr
731021211284810612282113150167168
PAT
PATCr
261273251349301348419295359403445425
Growth
PAT Growth%
24.44.5-8.039.1-14.015.620.6-29.521.712.210.41.0
NPM
NPM%
7.05.64.85.94.35.55.03.13.84.34.34.0
EPS
EPS₹
14.912.612.017.015.916.321.015.718.722.424.623.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
93185192192192192192192192192192
Reserves
ReservesCr
6918241,2191,4571,6461,8592,0762,1452,3242,1891,840
Current Liabilities
Current LiabilitiesCr
1,8861,7091,6531,8842,2101,9722,6362,3782,1932,2022,929
Non Current Liabilities
Non Current LiabilitiesCr
2222422083002693662603645897111,078
Total Liabilities
Total LiabilitiesCr
3,1243,2143,5414,2344,7004,7995,5845,4865,7035,5166,170
Current Assets
Current AssetsCr
1,4671,4221,5781,8652,1322,1382,7962,3052,2842,1932,772
Non Current Assets
Non Current AssetsCr
1,6571,7931,9642,3692,5682,6612,7883,1803,4193,3233,398
Total Assets
Total AssetsCr
3,1243,2143,5414,2344,7004,7995,5845,4865,7035,5166,170
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
93185192192192192192192192192192
Reserves
ReservesCr
6918241,2191,4571,6461,8592,0762,1452,3242,1891,840
Current Liabilities
Current LiabilitiesCr
1,8861,7091,6531,8842,2101,9722,6362,3782,1932,2022,929
Non Current Liabilities
Non Current LiabilitiesCr
2222422083002693662603645897111,078
Total Liabilities
Total LiabilitiesCr
3,1243,2143,5414,2344,7004,7995,5845,4865,7035,5166,170
Current Assets
Current AssetsCr
1,4671,4221,5781,8652,1322,1382,7962,3052,2842,1932,772
Non Current Assets
Non Current AssetsCr
1,6571,7931,9642,3692,5682,6612,7883,1803,4193,3233,398
Total Assets
Total AssetsCr
3,1243,2143,5414,2344,7004,7995,5845,4865,7035,5166,170

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
168897354448240-2-1208746789691,281
Investing Cash Flow
Investing Cash FlowCr
-428-63-253-237-255-187-208-284-327-82-150
Financing Cash Flow
Financing Cash FlowCr
278-812-125-21736189311-594-328-901-869
Net Cash Flow
Net Cash FlowCr
1922-24-6210-17-523-13262
Free Cash Flow
Free Cash FlowCr
43702109207-18-251-3885953017581,047
CFO To PAT
CFO To PAT%
64.4328.8140.9128.279.8-0.5-28.6295.9188.6240.3287.8
CFO To EBITDA
CFO To EBITDA%
56.2204.979.998.249.1-0.3-18.0167.296.7118.8148.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
168897354448240-2-1208746789691,281
Investing Cash Flow
Investing Cash FlowCr
-428-63-253-237-255-187-208-284-327-82-150
Financing Cash Flow
Financing Cash FlowCr
278-812-125-21736189311-594-328-901-869
Net Cash Flow
Net Cash FlowCr
1922-24-6210-17-523-13262
Free Cash Flow
Free Cash FlowCr
43702109207-18-251-3885953017581,047
CFO To PAT
CFO To PAT%
64.4328.8140.9128.279.8-0.5-28.6295.9188.6240.3287.8
CFO To EBITDA
CFO To EBITDA%
56.2204.979.998.249.1-0.3-18.0167.296.7118.8148.4

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
12,2359,7787,07410,0738,4967,9319,35414,49910,27713,008
Price To Earnings
Price To Earnings
53.429.723.132.121.126.326.033.721.729.1
Price To Sales
Price To Sales
2.41.71.01.61.00.81.01.51.01.2
Price To Book
Price To Book
8.75.93.94.93.83.43.76.15.16.4
EV To EBITDA
EV To EBITDA
28.422.215.719.515.117.915.319.413.417.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
17.318.718.818.317.521.218.815.618.620.320.720.7
OPM
OPM%
8.08.98.57.77.09.08.05.67.38.78.48.0
NPM
NPM%
7.05.64.85.94.35.55.03.13.84.34.34.0
ROCE
ROCE%
20.927.623.025.115.816.615.612.714.818.220.820.8
ROE
ROE%
33.427.117.821.216.416.918.512.614.316.921.921.9
ROA
ROA%
8.48.57.18.36.47.27.55.46.37.37.27.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
12,2359,7787,07410,0738,4967,9319,35414,49910,27713,008
Price To Earnings
Price To Earnings
53.429.723.132.121.126.326.033.721.729.1
Price To Sales
Price To Sales
2.41.71.01.61.00.81.01.51.01.2
Price To Book
Price To Book
8.75.93.94.93.83.43.76.15.16.4
EV To EBITDA
EV To EBITDA
28.422.215.719.515.117.915.319.413.417.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
17.318.718.818.317.521.218.815.618.620.320.720.7
OPM
OPM%
8.08.98.57.77.09.08.05.67.38.78.48.0
NPM
NPM%
7.05.64.85.94.35.55.03.13.84.34.34.0
ROCE
ROCE%
20.927.623.025.115.816.615.612.714.818.220.820.8
ROE
ROE%
33.427.117.821.216.416.918.512.614.316.921.921.9
ROA
ROA%
8.48.57.18.36.47.27.55.46.37.37.27.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Godrej Agrovet is an R&D-driven agribusiness that exists to raise the productivity of Indian farmers - by making better animal feed, protecting crops, growing oil palm, and processing milk and chicken - across a chain that stretches from the soil to the supermarket shelf. It was incorporated in 1991 as part of the century-old Godrej Group and has since assembled a deliberately diversified set of five businesses, each buffering the others against the wild price swings of food and agriculture. The recurring pattern is to go deep at the farmer’s end - with proprietary R&D, direct procurement, and farmer-financing tools - and then capture more value by moving downstream into branded products and refining. # Business segments Five engines at different stages - a compound-feed cash cow, an oil-palm profit engine, two consumer-facing platforms in dairy and poultry, and a crop-protection specialist - each built to de-risk the others. ## 1. Animal feed: the volume engine that feeds the nation’s protein **It sells over a million tonnes of compound feed a year to livestock farmers, turning raw grains into milk, meat and eggs - and its fortunes rise when farmer incomes rise.** - **Paid by the tonne** - the business manufactures and sells compound feed for cattle, broiler, layer, fish and shrimp, with cattle feed alone making up roughly half the volumes. In FY26 it sold 1,646,545 tonnes, making it the company’s largest segment by revenue. - **R&D that lifts yields** - the Nadir Godrej Centre for Animal Research in Nashik runs farms and labs staffed by veterinary scientists who work on getting more milk or meat from the same feed, which is the promise the company makes to its customers. - **A brand in an unorganised market** - its flagship ‘Samruddhi’ brand leads in Western India, but most of the market is still unbranded local feed, so when milk prices rise and farmers have more to spend, they upgrade to compound feed. ## 2. Oil palm: the plantation-to-refinery profit centre **India’s largest domestic crude palm oil producer, it plants saplings with farmers, buys back the fruit bunches for decades, and now refines the oil itself - capturing margin at every step.** - **The fruit is the cost** - more than 90% of input costs are the fresh fruit bunches it buys from farmers, so the oil extraction ratio - how much oil it squeezes from each bunch - is the number that matters most, and it hit an all-time high in FY26. - **Forward-integrated into refining** - in 2023 it commissioned its first refinery and solvent extraction plant at Chintalapudi, Andhra Pradesh, so it now sells value-added products like stearin and palm fatty acid distillates, not just raw oil. The refinery runs partly on third-party crude palm oil because its capacity exceeds its own crop. - **A government-backed land-grab** - under India’s National Mission on Edible Oils, the company has been allotted new areas in Telangana, Gujarat, Assam, Tripura and other states, with a goal of adding 60,000 hectares of plantation over five years. A new integrated palm complex in Telangana will include India’s first seed garden, capable of supplying seeds for 90,000 acres. ## 3. Crop care: the chemistry business that protects the harvest **It sells herbicides, fungicides and insecticides through its own portfolio and via in-licensed molecules from Japanese innovators, while its subsidiary Astec makes the active ingredients behind them.** - **In-licensed science, sold through its own network** - the standalone business brings in advanced molecules like ‘Gracia’ and ‘Rashinban’ from Nissan Chemical and ‘Ashitaka’ from ISK Japan, then pushes them through a widespread dealer network that reaches farmers at the district level. - **One-third traded to hold the farmer** - about a third of the crop protection business is products it buys from others and resells, simply to offer a complete crop solution so the farmer doesn’t walk away. - **Astec: the export-facing CDMO engine** - its 64.75%-owned subsidiary Astec LifeSciences makes active ingredients for its own enterprise products and for global agrochemical companies under long-term contracts, with the CDMO (contract manufacturing) arm earning margins above 25%. Astec achieved EBITDA break-even in FY26 after a loss-making year, helped by higher CDMO volumes. - **Backward-integrated as a shield** - Astec can make most of its own raw materials in-house, so if a Chinese supplier raises prices or supply tightens - and China still supplies about 47% of its imports - it can switch to internal production quickly. ## 4. Dairy: the southern milk brand going up the value chain **It runs one of South India’s largest private dairies under the ‘Godrej Jersey’ name, and it is deliberately shifting the mix from plain milk pouches to higher-margin curd, paneer and flavoured milk.** - **Milk spread is the profit dial** - the business earns the difference between what it pays farmers for milk and what it sells it for, so it has been cutting procurement inefficiencies: it reduced its chilling-centre count from over 100 to fewer than 60 to tighten costs. - **Eight plants, now nearly wholly owned** - it operates eight composite dairy plants and a milk-powder plant in Ongole, and in 2025 the parent company bought out almost all the remaining minority stake in Creamline Dairy for ₹930 crore, taking ownership to 99.32%. - **Betting on a ₹10 flavoured milk** - it launched ‘Milky Shots’ at a ₹10 price point to build habit among younger consumers, and has signed agreements with the Andhra Pradesh and Telangana governments to invest a combined ₹220 crore in new processing capacity. ## 5. Poultry and processed foods: the branded-protein pivot **It is walking away from the volatile live-bird commodity trade and betting instead on packaged chicken under ‘Real Good Chicken’ and frozen snacks under ‘Yummiez’.** - **Branded, not live** - branded revenue crossed 80% of the segment in FY26, with volumes growing about 9%, while the company deliberately shrinks its exposure to the live-bird wet market that still makes up 95% of Indian poultry sales. - **Two brands, two channels** - ‘Real Good Chicken’ and ‘Yummiez’ operate in the B2C space through value-added products, while in the B2B vertical the company supplies processed chicken to quick-service restaurants and hotel chains across more than 35 cities. - **Now fully owned** - the business was a 51:49 joint venture with Tyson Foods until August 2024, when Godrej Agrovet bought out Tyson’s stake and made it a wholly-owned subsidiary, later renaming it Godrej Foods Limited. # Group structure and partners **The company sits inside the Godrej Group as a listed subsidiary of Godrej Industries, with a web of wholly-owned and majority-owned arms that give it direct control over its dairy, poultry and agrochemical manufacturing.** - Godrej Industries Limited held 64.87% of the company as of March 2025, and following the Godrej family settlement in 2024, management control rests with the ABG and NBG families, who hold the exclusive right to the ‘Godrej’ brand in agriculture, dairy, foods and chemicals. - The subsidiary chain includes Astec LifeSciences (64.75%, with its own step-down units in India and Colombia), Creamline Dairy Products (99.32% after a buyout of minority partners in 2025), Godrej Foods Limited (wholly-owned after the Tyson exit), Godrej Cattle Genetics (wholly-owned, producing high-yield cow embryos in labs), and Godvet Agrochem Limited (wholly-owned). - A 50:50 joint venture in Bangladesh, ACI Godrej Agrovet, makes cattle, poultry and aqua feed and ranks among the top players in each category in that country.

Documents — Godrej Agrovet Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/sxmnva3fzeydum0gjb9s6h9y.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/e46dvod8srhgunqpt2qfwic8.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/nmw63x7xipf0qmrgfhxzkiss.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/q5q8zxgzaka3yg1pk0ousa4j.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/vfxzwr6abexyf9ppmaw72ho3.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/qgiwdh3c0gds9sw1pli8jn4k.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/tlv8fcb79sn3bu0ueifsj8ea.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/8qan26hkfzb877aquuxt878f.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/hm9nsdp2d2tdn2m86k8j1zo6.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/ihutvwz4di5x72xbsfqp8eig.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/mc7tq74gpgk8fll62bspz72w.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/f7j5rm6tkt50i43l0u19maod.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/xy9t164ca2qvtiod0hc5uf2i.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/zz0koxa5wjfqljo8422xcyzz.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/z5tjsn9y0ad9ue7muc3kuwlx.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/fjqkog1hpgxvy1xv5pru28i5.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/c1u3sncgdzsvo1tc7awlrot5.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/43wg06vnec7spab8apkzqiwi.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/v7brc7bjate21o72rm9bzfu6.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/o6wh0eob557xxtxiujqjalr7.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/b41d363cr81m7rug9haclf2e.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/lv0shggtswkfbie4hk6yd4ei.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/s4msfcyaj1s3icbcu5gz5wjx.pdf
  • Q1 FY2025 Investor Presentation (Jun 2024, PDF): https://www.stockscans.in/document/dp396066b7ng9r91cjx891rw.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/pnahjowilva778w7941d4vgm.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/9nlippjbld5dfh4br0ckdny6.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/7ds1suohg7xfd7lvjzdvtj7i.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/4ltfjg7nrih88qnl0u7utk59.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/3zdntfrqndi3sjwal3kcz1vn.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/2wqbfkwb068lwj1tl9qklkb9.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/4s7j6ldwcmns2f7qj90tbysz.pdf

Concall Transcript Summaries — Godrej Agrovet Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AGODREJAGRO/transcript-notes/202606/sxmnva3fzeydum0gjb9s6h9y.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AGODREJAGRO/transcript-notes/202603/e46dvod8srhgunqpt2qfwic8.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AGODREJAGRO/transcript-notes/202512/nmw63x7xipf0qmrgfhxzkiss.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AGODREJAGRO/transcript-notes/202509/q5q8zxgzaka3yg1pk0ousa4j.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AGODREJAGRO/transcript-notes/202506/vfxzwr6abexyf9ppmaw72ho3.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AGODREJAGRO/transcript-notes/202503/qgiwdh3c0gds9sw1pli8jn4k.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AGODREJAGRO/transcript-notes/202412/tlv8fcb79sn3bu0ueifsj8ea.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AGODREJAGRO/transcript-notes/202409/8qan26hkfzb877aquuxt878f.pdf